| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 09/29/2005 | US20050214765 Process for isolating nucleic acid with chaotrope agents and ammonium compounds |
| 09/29/2005 | US20050214759 Enzymatic redox labelling of nucleic acids |
| 09/29/2005 | US20050214756 Cell visual characteristic-modifying sequences |
| 09/29/2005 | US20050214738 Animal models comprising rapamycin binding (FRB) domain and target of rapamycin (TOR) sequence for use in identifying modulators of cellular pathways |
| 09/29/2005 | US20050214321 Recombinant icosahedral virus like particle production in pseudomonads |
| 09/29/2005 | US20050214320 Mycobacterium vaccae; enhancement of immune Th1 or Th2 responses to heterologous antigens; tuberculosis, autoimmune thyroiditis, insulin-dependent diabetes mellitus, multiple sclerosis, Crohn's disease, peptic ulcers, organ transplant rejection, sarcoidosis, asthma, allergic rhinitis, cancer, lupus |
| 09/29/2005 | US20050214316 Generating and sequencing an infectious bursal disease virus cDNA from sample suspected of having a strain of IBDV, aligning the sequence with one or more IBDV sequences, and comparing relatedness of aligned IBDV sequences; selecting a vaccine for chickens, ducks, geese, pheasants, quail and turkeys. |
| 09/29/2005 | US20050214315 Antibodies to human IL-17F and other CTLA-8-related proteins and methods related thereto |
| 09/29/2005 | US20050214313 Extracellular domain of CTLA4, with (a) an alanine at position +29 substituted with tyrosine, leucine, tryptophan, or threonine, and (b) a leucine at position +104 substituted with glutamic acid; binds CD80 and/or CD86 with greater avidity; inhibiting graft versus host disease |
| 09/29/2005 | US20050214306 Surface proteins of leptospira |
| 09/29/2005 | US20050214305 VEGI, an inhibitor of angiogenesis and tumor growth |
| 09/29/2005 | US20050214281 G-protein coupled receptor |
| 09/29/2005 | US20050214276 Delta 4, 5 glycuronidase and uses thereof |
| 09/29/2005 | US20050214267 Compositions and methods for controlling insects related to the octopamine receptor |
| 09/29/2005 | DE102004062386A1 Monacolin K-Biosynthese-Gene Monacolin K biosynthesis genes |
| 09/29/2005 | CA2815554A1 Irna agents targeting vegf |
| 09/29/2005 | CA2559955A1 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 09/29/2005 | CA2559280A1 Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing |
| 09/29/2005 | CA2559161A1 Irna agents targeting vegf |
| 09/29/2005 | CA2558749A1 Polynucleotide synthesis |
| 09/29/2005 | CA2558649A1 Neoplasia diagnostic compositions and methods of use |
| 09/29/2005 | CA2546157A1 Improved expression systems with sec-system secretion |
| 09/28/2005 | EP1580282A1 Use of human RPS6KA6-related gene variant for diagnosing T cell lymphoblastic lymphoma |
| 09/28/2005 | EP1579013A2 Method for profiling and identifying persons by using data samples |
| 09/28/2005 | EP1579010A2 Susceptibility gene for myocardial infarction; methods of treatment |
| 09/28/2005 | EP1579007A2 Method and means for determining specific conditions or changes in the uterine epithelium and in the epithelium of other organs |
| 09/28/2005 | EP1579004A2 Screening methods for identification of efficient pre-trans-splicing molecules |
| 09/28/2005 | EP1578996A2 Compositions and methods for the diagnosis and treatment of tumor |
| 09/28/2005 | EP1578992A2 Methods of determining precise herg interactions and aletring compounds based on said interactions |
| 09/28/2005 | EP1578991A2 Methods of diagnosing & treating diabetes and insulin resistance |
| 09/28/2005 | EP1578982A2 Nucleic acid amplification methods |
| 09/28/2005 | EP1578965A2 Sorbent and method for the separation of plasmid dna |
| 09/28/2005 | EP1578954A2 5' cpg nucleic acids and methods of use |
| 09/28/2005 | EP1578951A2 Dna polymerases with reduced base analog detection activity |
| 09/28/2005 | EP1578943A2 NOVEL VARIANT i HYPROCREA JECORINA /i CBH1 CELLULASES |
| 09/28/2005 | EP1578942A2 ANTISENSE MODULATION OF mitoNEET EXPRESSION |
| 09/28/2005 | EP1578940A2 Methods and compositions for diagnosing dysplasia |
| 09/28/2005 | EP1578939A2 Translational control by small, non-translatable rnas |
| 09/28/2005 | EP1578933A2 Compositions and methods for si-rna inhibition of angiogenesis |
| 09/28/2005 | EP1578932A2 Synthetic tag genes |
| 09/28/2005 | EP1578930A2 Cngh0004 polypeptides, antibodies, compositions, methods and uses |
| 09/28/2005 | EP1578929A2 Nematode phosphoethanolamine n-methyltransferase-like sequences |
| 09/28/2005 | EP1578926A2 Novel prostate tumor-specific promoter |
| 09/28/2005 | EP1578924A2 Genomic screen for epigenetically silenced tumor suppressor genes |
| 09/28/2005 | EP1578923A2 Soluble mic polypeptides as markers for diagnosis, prognosis and treatment of cancer and autoimmune diseases or conditions |
| 09/28/2005 | EP1578921A2 Mammalian migration inducting gene and methods for detection and inhibition of migrating tumor cells |
| 09/28/2005 | EP1578919A2 Endogenous retrovirus up-regulated in prostate cancer |
| 09/28/2005 | EP1578915A2 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof |
| 09/28/2005 | EP1578914A2 Human ion channels |
| 09/28/2005 | EP1578910A2 Nitrilases |
| 09/28/2005 | EP1578907A2 Secreted protein, ztnf9 |
| 09/28/2005 | EP1578905A2 Novel proteins and nucleic acids encoding same |
| 09/28/2005 | EP1578902A2 Neurotransmission-associated proteins |
| 09/28/2005 | EP1578779A2 Erythropoietin receptor binding antibodies |
| 09/28/2005 | EP1578772A2 Cytokines and cytokine receptors with reduced immunogenicity |
| 09/28/2005 | EP1578770A2 Novel human egf-family proteins and polynucleotides encoding the same |
| 09/28/2005 | EP1578765A2 Sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| 09/28/2005 | EP1578764A2 Thymidylate synthase polymorphisms for use in screening for cancer susceptibility |
| 09/28/2005 | EP1578761A2 Structural motifs and oligomeric compounds and their use in gene modulation |
| 09/28/2005 | EP1578760A2 Compositions and methods for the diagnosis and treatment of tumor |
| 09/28/2005 | EP1578759A1 Pyrroles substituted by oligonucleotides |
| 09/28/2005 | EP1578446A2 Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 09/28/2005 | EP1578399A2 Methods for rapid identification of pathogens in humans and animals |
| 09/28/2005 | EP1578385A2 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| 09/28/2005 | EP1578382A2 Botulinum neurotoxin b receptors and use thereof |
| 09/28/2005 | EP1578373A2 Novel compositions and methods for the treatment of immune related diseases |
| 09/28/2005 | EP1578364A2 Compositions and methods for the treatmentof immune related diseases |
| 09/28/2005 | EP1578357A2 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases |
| 09/28/2005 | EP1578356A2 Assays to monitor amyloid precursor protein processing |
| 09/28/2005 | EP1578252A2 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases |
| 09/28/2005 | EP1071691B1 Method for isolating and purifying nucleic acids |
| 09/28/2005 | CN1675378A Identification of oligonucleotides for the capture, detection and quantitation of hepatitis A viral nucleic acid |
| 09/28/2005 | CN1675377A Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores |
| 09/28/2005 | CN1675376A Inhibitors of inflammatory gene activity and cholesterol biosynthesis |
| 09/28/2005 | CN1675372A Use of biomarkers for detecting ovarian cancer |
| 09/28/2005 | CN1675367A Method for producing ketocarotinoids and/or biosynthetic intermediate and/or secondary products |
| 09/28/2005 | CN1675359A Novel forms of interfering rna molecules |
| 09/28/2005 | CN1675353A Substances for preventing and treating autoimmune diseases |
| 09/28/2005 | CN1674931A T cell receptor CDR3 sequences and methods for detection |
| 09/28/2005 | CN1674778A Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids |
| 09/28/2005 | CN1220695C Inhibitors of nucleoside metabolism |
| 09/27/2005 | US6949659 cyanine, xanthene, porphyrin or coumarin dyes, used for marking probes, including nucleic acids and proteins |
| 09/27/2005 | US6949639 lanthanide(III) chelates |
| 09/27/2005 | US6949635 use with DNA polymerases that are thermostable or which contain an altered dNMP binding site |
| 09/27/2005 | US6949624 mediates the assembly of transcription repressor complexes by altering chromatin structure |
| 09/27/2005 | US6949378 C. elegans gro-1 gene |
| 09/27/2005 | US6949373 given amino acid sequence; telomerase motif; use as drug target for cancer |
| 09/27/2005 | US6949370 High fidelity thermostable ligase and uses thereof |
| 09/27/2005 | US6949368 Compositions and methods for enhancing polynucleotide amplification reactions |
| 09/27/2005 | US6949367 incubating a polynucleotide containing a target sequence with one or more modified oligonucleotide primers complementary to the target sequence, in the presence of a polymerizing enzyme and nucleotide substrates |
| 09/27/2005 | US6949366 Complexing; purified polypeptide |
| 09/27/2005 | US6949341 Diagnosing genetic disorders |
| 09/27/2005 | US6949337 Contacting human vpr interacting protein with a test compound and comparing the affinity of the vpr in the presence and absence of it |
| 09/27/2005 | US6949246 Monoclonal/polyclonal antibodies for serodetection and treatment of mycobacterium infections |
| 09/27/2005 | US6949242 Retroviral vector for the transfer and expression of genes for therapeutic purposes in eukaryotic cells |
| 09/27/2005 | CA2149120C Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
| 09/22/2005 | WO2005087943A1 Temporal or spatial characterization of biosynthetic events in living organisms by isotopic fingerprinting under conditions of imposed isotopic gradients |
| 09/22/2005 | WO2005087930A1 Polynucleotides for the detection of escherichia coli o157 |
| 09/22/2005 | WO2005087926A2 Multiple promoter expression cassettes for simultaneous delivery of rnai agents |
| 09/22/2005 | WO2005087810A2 Dimeric fusion proteins and materials and methods for producing them |